Weekly Overseas Health IT Links – 29th October, 2022.
This report presents CDC findings on telehealth use trends in 2021. It includes data from the National Health Interview Survey, a nationally representative household survey conducted throughout the year by the National Center for Health Statistics. -----https://www.usnews.com/news/health-news/articles/2022-10-13/women-older-adults-more-likely-to-use-telemedicine-in-2021Who Used Telemedicine in 2021?New data shows which groups have been most likely to use a health care option popular during the pandemic.By Christopher WolfOct. 13, 2022, at 12:01 a.m.More than 1 in 3 adults used telemedicine in the past year in 2021, ac...
Source: Australian Health Information Technology - October 29, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Tackling racial disparities in cancer care by creating new ways for institutions to operate
At 84, Emma Shuford found a lump in her breast. After a lumpectomy, she was diagnosed with locally aggressive breast cancer. Her doctors said it was treatable but she needed radiation to help stop it from growing. At first, she refused. Because of her age and a chronic leg injury, she didn ’t feel safe drivingRead more …Tackling racial disparities in cancer care by creating new ways for institutions to operate originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - October 31, 2021 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/joseph-d-stern" rel="tag" > Joseph D. Stern, MD, PhD < /a > < /span > Tags: Conditions Oncology/Hematology Source Type: blogs
Localized Prostate Cancer Therapy: Interview with Shyam Natarajan, CEO of Avenda Health
Avenda Health, a medtech company based in Santa Monica, California has developed the Focal Therapy System. It provides AI-powered prostate cancer therapy with the aim of treating only tumorous tissues, while reducing side-effects compared with conventional therapies. The system recently received FDA breakthrough designation. Â
At present, there are limited treatment options for men with prostate cancer, with surgery and radiation therapy being the most commonly used approaches. However, these techniques pose significant risks for patients, including urinary and sexual dysfunction. The Avenda Focal Therapy System uses A...
Source: Medgadget - June 7, 2021 Category: Medical Devices Authors: Conn Hastings Tags: Exclusive Informatics Oncology Urology Source Type: blogs
Evaluation of the Surgical Specimen After Neoadjuvant Systemic Therapy
ConclusionPostneoadjuvant systemic therapy histopathological changes are complex, and careful systematic review of the specimen is required for accurate diagnosis and follow-up treatment. For pathological complete response to be used as an indicator of response to novel therapies, it is essential to have a standardized way in which residual disease is measured and reported. We designed the recommendations specifically for the clinical trial setting; however, they can be optionally incorporated into routine practice because, in our opinion, standardization is most effective when uniformly applied. Hopefully, such standardiz...
Source: Oncopathology - March 23, 2021 Category: Cancer & Oncology Tags: breast Breast Biopsy Procedure breast cancer Source Type: blogs
More intensive treatment of DCIS reduces the risk of invasive breast cancer
This study showed that increased cancer risk persisted for more than 15 years after a diagnosis of DCIS, and that more intensive therapy than lumpectomy alone — whether with mastectomy, radiation therapy, or endocrine therapy — reduced the risk of invasive breast cancer among women with DCIS. The lowest risk of invasive breast cancer was in women who chose mastectomy.
The risk of invasive breast cancer was seen regardless of severity of DCIS. Women who had low- or moderate-grade DCIS, as well as high-grade DCIS, had long-term increased risk.
Women who are recently diagnosed with DCIS should work with their treatment te...
Source: Harvard Health Blog - January 19, 2021 Category: Consumer Health News Authors: Kathryn Rexrode, MD, MPH Tags: Breast Cancer Women's Health Source Type: blogs
Is it time to give up your annual mammogram?
If you dread your annual mammogram, you’re not alone. For many women, this breast cancer screening examination can be painful, stressful, and just an overall hassle.
You may wonder, are you old enough to give it up? If you’re over age 75, the answer is: maybe or maybe not. The fact is, breast cancer screening isn’t right for all older adults, but there’s no expert consensus on the right age to stop. This is mostly because scientific evidence in this area is lacking, says Dr. Kathryn Rexrode, associate professor of medicine at Harvard Medical School and chief of the Division of Women’s Health at Brigham and Womenâ...
Source: Harvard Health Blog - May 1, 2020 Category: Consumer Health News Authors: Kelly Bilodeau Tags: Breast Cancer Healthy Aging Managing your health care Screening Women's Health Source Type: blogs
EnVisio Surgical Navigation System for Breast Lumpectomies Cleared in U.S.
Elucent Medical, a firm based in Eden Prairie, MN, won FDA clearance for its EnVisio Navigation System. The technology involves placing a wireless SmartClip implantable marker within the breast that identifies the location of the tissue to be removed. Normally guidewires are used to locate the target tissue, which extend out through the skin. The SmartClip marker remains completely implanted until the lumpectomy. It’s actually possible to use multiple SmartClips to target different locations within the breast, and this is aided by the fact that each of the implants has its own radiofrequency signature identifying it...
Source: Medgadget - April 12, 2019 Category: Medical Devices Authors: Editors Tags: Pathology Radiology Surgery Source Type: blogs
Safer surgery: Steps you can take
Chances are high that most of us will have a surgical procedure at some point during our lives. Estimates based on 2002 data in three states suggest Americans have a lifetime average of nine surgical procedures. In 2010 in the United States, there were an estimated 1.4 million inpatient procedures, ranging from childhood tonsillectomies, breast lumpectomies, and gallbladder removal to cataract surgeries, hernia repairs, and hip or knee replacements. And the rate of surgical procedures continues to rise. So it’s valuable to know what you can do to make safer surgery and a successful outcome more likely.
How do I choos...
Source: Harvard Health Blog - March 28, 2019 Category: Consumer Health News Authors: Susan Abookire, BSEE, MD, MPH, FACP Tags: Health Managing your health care Safety Surgery Source Type: blogs
So glad we are done with January!
It was harder than I thought. The first was our anniversary. UGH! The 16th was the six-month anniversary of his passing. The 19th was his 65th birthday. And if he were still here, he would have done it big! For his 50th, he took us on a 15 day cruise through the Panama Canal. I can't help wonder what he would have done for his 65th? He was always chatting about taking a world cruise.So I cried a bit. Then I decided to go buy a case of our favorite wine. It's made locally. I'm not a drinker - the last case we bought, I gave every bottle away as a gift. But that nig...
Source: Wife of a Diabetic - February 5, 2019 Category: Endocrinology Source Type: blogs
EZbra Breast Dressing to Make Post-Op Recovery Easier, Safer
EZbra Advanced Wound Care, a firm based in Tel Aviv, Israel, is releasing in the U.S. its innovative breast dressing for recovery following procedures such as biopsies, lumpectomies, reconstructions, and placement of implants. The company hopes that its EZbra all-in-one device will become a standard of care, as currently there is no universally accepted methods for breast dressing.
The device comes sterile and is intended for one-time use, avoiding the potential for cross contamination. The level of compression that is placed upon the breasts can be easily adjusted at various points to achieve post-op requirements. It abso...
Source: Medgadget - December 3, 2018 Category: Medical Devices Authors: Editors Tags: Ob/Gyn Plastic Surgery Source Type: blogs
Optoacoustic Guidewire System for Breast Cancer Localization
Breast lumpectomy for breast CA is an imprecise procedure that too often results in cancerous tissue being left behind. About a quarter of patients have to come back and go through the surgery yet again.
This is in large part due to the fact that guidewires are the standard way to point to the location of a tumor. While guidewires are better than nothing, they are crude and not very precise. Radioactive seeds are another option, but they have safety concerns and radio-based technologies are limited in their targeting and they can interfere with other equipment.
Engineers at Boston University have now developed an optoacous...
Source: Medgadget - October 25, 2018 Category: Medical Devices Authors: Editors Tags: Oncology Radiology Surgery Source Type: blogs
What's in a name?
From time to time I have commented on the controversies over cancer screening. Most people assume that screening is an unqualified good, that early detection of cancer saves lives. Whenever some panel proposes recommending less screening, we hear screaming and yelling from advocates who claim they are trying to " ration " health care to save money at the expense of people ' s lives.In fact,as a bunch of Australians and a Minnesotan explain in BMJ, there are a few conditions called " cancer " that you are better off not treating, or perhaps treating very conservatively. These include what is called ductal carcinoma in situ ...
Source: Stayin' Alive - August 13, 2018 Category: American Health Source Type: blogs
Screening mammograms: One recommendation may not fit all
To date, official recommendations on when and how often a woman should have a screening mammogram, have been based on risk factors (such as age, a family history of breast cancer, a personal history of radiation to the chest), genetic testing (the BRCA test, for example), or troubling results from a previous biopsy. Race and ethnicity have not officially factored into the equation — yet.
Does race matter when it comes to screening mammograms?
A recent study by Harvard doctors at Massachusetts General Hospital reinforces prior data suggesting that race and ethnicity can be a separate risk factor for breast cancer, and sho...
Source: Harvard Health Blog - April 16, 2018 Category: Consumer Health News Authors: Monique Tello, MD, MPH Tags: Breast Cancer Health Prevention Screening Women's Health Source Type: blogs
